Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report

We report the first successful treatment with the IL-1 receptor antagonist anakinra, in association with the most promising and available antiviral therapy, of a severe case of novel coronavirus disease 2019 (COVID-19). We describe the diagnosis, clinical course, and management of the case, includin...

Descripción completa

Detalles Bibliográficos
Autores principales: Franzetti, Marco, Pozzetti, Ugo, Carugati, Manuela, Pandolfo, Alessandro, Molteni, Chiara, Faccioli, Paolo, Castaldo, Gioacchino, Longoni, Ernesto, Ormas, Valentina, Iemoli, Enrico, Piconi, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228890/
https://www.ncbi.nlm.nih.gov/pubmed/32422376
http://dx.doi.org/10.1016/j.ijid.2020.05.050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228890/
https://www.ncbi.nlm.nih.gov/pubmed/32422376
http://dx.doi.org/10.1016/j.ijid.2020.05.050

Ejemplares similares